Literature DB >> 8753852

Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules.

M Ibe1, Y I Moore, K Miwa, Y Kaneko, S Yokota, M Takiguchi.   

Abstract

The binding capacity of one-hundred-and-seventy-two 8-mer to 11-mer peptides carrying HLA-A24 anchor residues to HLA-A*2402 molecules was analyzed by using a HLA class I stabilization assay. Most (76. 2%) of these peptides bound to HLA-A*2402 molecules. These results confirmed previous findings that Tyr and Phe at P2 as well as Phe, Trp, Ile, and Leu at the C-terminus were main anchor residues for HLA-A*2402. Tyr at P2 was a stronger anchor residue than Phe, while bulky aromatic hydrophobic residues Phe and Trp at the C-terminus are stronger anchors than aliphatic hydrophobic residues Ile and Leu. These results were also supported by an analysis using a panel of mutated 9-mer peptides at P2 and P9. Taken together, these results suggest that HLA-A*2402 molecules have deep B- and F-pockets because they favor peptides carrying bulky aromatic hydrophobic residues at P2 and the C-terminus. The affinity of 8-mer peptides was significantly lower than that of 9-mer to 11-mer peptides, while there was no difference in affinity between 9-mer, 10-mer, and 11-mer peptides. The affinity of peptides carrying bulky aromatic hydrophobic residues at the C-terminus was higher than that of peptides carrying aliphatic hydrophobic residues in each of the 8-mer to 11-mer peptides, though the greatest difference in affinity was observed in 11-mer peptides. The strong interaction of side chains of these anchor residues with the corresponding pockets may permit the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8753852     DOI: 10.1007/bf02602551

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  32 in total

1.  Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

Authors:  K C Parker; M A Bednarek; L K Hull; U Utz; B Cunningham; H J Zweerink; W E Biddison; J E Coligan
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

2.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

3.  A quantitative assay of peptide-dependent class I assembly.

Authors:  J Elvin; V Cerundolo; T Elliott; A Townsend
Journal:  Eur J Immunol       Date:  1991-09       Impact factor: 5.532

4.  Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.

Authors:  R Maier; K Falk; O Rötzschke; B Maier; V Gnau; S Stevanović; G Jung; H G Rammensee; A Meyerhans
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 5.  Structure of peptides associated with MHC class I molecules.

Authors:  V H Engelhard
Journal:  Curr Opin Immunol       Date:  1994-02       Impact factor: 7.486

6.  Empty MHC class I molecules come out in the cold.

Authors:  H G Ljunggren; N J Stam; C Ohlén; J J Neefjes; P Höglund; M T Heemels; J Bastin; T N Schumacher; A Townsend; K Kärre
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

7.  Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease.

Authors:  K Falk; O Rötzschke; M Takiguchi; V Gnau; S Stevanović; G Jung; H G Rammensee
Journal:  Int Immunol       Date:  1995-02       Impact factor: 4.823

8.  Peptide motifs of HLA-A1, -A11, -A31, and -A33 molecules.

Authors:  K Falk; O Rötzschke; M Takiguchi; B Grahovac; V Gnau; S Stevanović; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.

Authors:  J Sutton; S Rowland-Jones; W Rosenberg; D Nixon; F Gotch; X M Gao; N Murray; A Spoonas; P Driscoll; M Smith
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

10.  Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries.

Authors:  K Udaka; K H Wiesmüller; S Kienle; G Jung; P Walden
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  9 in total

1.  Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.

Authors:  Hirokazu Koizumi; Masao Hashimoto; Mamoru Fujiwara; Hayato Murakoshi; Takayuki Chikata; Mohamed Ali Borghan; Atsuko Hachiya; Yuka Kawashima; Hiroshi Takata; Takamasa Ueno; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.

Authors:  Mamoru Fujiwara; Junko Tanuma; Hirokazu Koizumi; Yuka Kawashima; Kazutaka Honda; Saori Mastuoka-Aizawa; Sachi Dohki; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

3.  Mouse homologue of the human SART3 gene encoding tumor-rejection antigen.

Authors:  K Harada; A Yamada; T Mine; N Kawagoe; H Takasu; K Itoh
Journal:  Jpn J Cancer Res       Date:  2000-02

4.  Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients.

Authors:  Koji Tanaka; Nanae Harashima; Fumihiko Niiya; Yoshiaki Miyagi; Naoya Hida; Mika Ochi; Nobue Imai; Mamoru Harada; Kyogo Itoh; Shigeki Shichijo
Journal:  Jpn J Cancer Res       Date:  2002-02

5.  CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants.

Authors:  Andrew D Redd; Alessandra Nardin; Hassen Kared; Evan M Bloch; Andrew Pekosz; Oliver Laeyendecker; Brian Abel; Michael Fehlings; Thomas C Quinn; Aaron Ar Tobian
Journal:  medRxiv       Date:  2021-02-12

6.  Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine.

Authors:  Nozomi Kuse; Yu Zhang; Takayuki Chikata; Hung The Nguyen; Shinichi Oka; Hiroyuki Gatanaga; Masafumi Takiguchi
Journal:  Nat Commun       Date:  2022-09-06       Impact factor: 17.694

7.  Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection.

Authors:  Akihisa Shimizu; Ai Kawana-Tachikawa; Atsushi Yamagata; Chungyong Han; Dayong Zhu; Yusuke Sato; Hitomi Nakamura; Tomohiko Koibuchi; Jonathan Carlson; Eric Martin; Chanson J Brumme; Yi Shi; George F Gao; Zabrina L Brumme; Shuya Fukai; Aikichi Iwamoto
Journal:  Sci Rep       Date:  2013-11-06       Impact factor: 4.379

8.  Switching and emergence of CTL epitopes in HIV-1 infection.

Authors:  Chungyong Han; Ai Kawana-Tachikawa; Akihisa Shimizu; Dayong Zhu; Hitomi Nakamura; Eisuke Adachi; Tadashi Kikuchi; Michiko Koga; Tomohiko Koibuchi; George F Gao; Yusuke Sato; Atsushi Yamagata; Eric Martin; Shuya Fukai; Zabrina L Brumme; Aikichi Iwamoto
Journal:  Retrovirology       Date:  2014-05-21       Impact factor: 4.602

9.  CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants.

Authors:  Andrew D Redd; Alessandra Nardin; Hassen Kared; Evan M Bloch; Andrew Pekosz; Oliver Laeyendecker; Brian Abel; Michael Fehlings; Thomas C Quinn; Aaron A R Tobian
Journal:  Open Forum Infect Dis       Date:  2021-03-30       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.